Latest Breaking News On - Cholestatic pruritus - Page 1 : comparemela.com

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment Solutions RESEARCH…

Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting | Region

FOSTER CITY, Calif. (BUSINESS WIRE) May 18, 2024

Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting

- Seven abstracts highlighting ALGS and PFIC data, including three oral presentations - Long-term extension data from Phase 3 MARCH-ON PFIC study presented at plenary session and selected among the.

Reserve Dermatology and Aesthetics is Opening an All-New

Remoove LTD: Revolutionizing Advertising with Innovative